RGEN
Repligen Corporation
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$167.08
−1.49%Margins
Gross margin
51.1%
EBITDA margin
15.5%
EBIT margin
8.3%
Net margin
5.3%
FCF margin
14.1%
2.0%
Return on equity
1.4%
Return on assets
2.3%
Return on invested capital
0.27x
Asset turnover
$134.9M
Cash from operations
$14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026